Compare Moderna, Inc. (MRNA) vs Public Storage (PSA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Public Storage — how do they compare? Moderna, Inc. trades at $195.7 (market cap $78.44B), while Public Storage trades at $285.55 (market cap $52.69B). The key difference: Moderna, Inc. is the larger of the two by market cap, and Public Storage pays a 4.26% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Moderna, Inc. for 59 Days and Public Storage for 130 Days on average.
| MRNA | PSA | |
|---|---|---|
Market Cap | $78.44B | $52.69B |
Volume | 14,597,511 | 975,662 |
Sector | Health | Real Estate |
52-Week High | $203.46 | $330.47 |
52-Week Low | $22.36 | $258.44 |
Typical Hold Time | 59 Days | 130 Days |
Enterprise Value | $74.59B | $66.96B |
Dividend Yield | — | 4.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $196.48, up 4.81% amid Nasdaq-100 inclusion news, though it remains well below the analyst consensus target of $115.70. The stock shows bullish technical momentum with recent earnings beats, but faces fundamental challenges with negative profit margins and declining revenue from pandemic-era highs. The company's cash flow improved in 2025, turning positive for the first time since 2022, while its pipeline, including oncology vaccines, attracts investor interest despite valuation concerns.
Outlook: Near-term momentum from index fund buying and pipeline updates may support the stock, but high valuation multiples and persistent losses pose significant risks. Long-term growth depends on successful commercialization of non-COVID products, with current prices reflecting optimistic scenarios. Investors should weigh the potential of the mRNA platform against execution risks and competitive pressures.
Public Storage (PSA) trades at $285.52, down 0.12% on the day, with a bearish technical signal. The stock shows strong profitability with a 41.8% net income margin and has beaten earnings estimates for three consecutive quarters. Recent corporate actions include the completion of the Public Storage Canada acquisition and a $3.00 dividend declared for payment in October 2026. Analyst consensus is a Buy with a $328.33 price target, implying potential upside.
The outlook is mixed; strong fundamentals and analyst support suggest long-term value, but near-term technical weakness and fluctuating cash flows pose risks. Investors should weigh the high valuation multiples against the company's operational resilience and dividend yield.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →
